主页 > 医药生命 >

【medical-news】有效干预加速社区获得性肺炎的治

Intervention Speeds Community-Acquired Pneumonia Therapy
By David Douglas

NEW YORK (Reuters Health) Jan 15 - Improved management has prompted a substantial increase in the number of patients with community-acquired pneumonia (CAP) who receive appropriate antibiotics in a timely fashion, UK researchers report in the January issue of Thorax.

As lead investigator Dr. Gavin Barlow told Reuters Health, "National Health Service hospitals can potentially reduce door-to-needle time for patients with pneumonia by implementing a relatively simple intervention."

Dr. Barlow of Castle Hill Hospital, Cottingham and colleagues note that an audit showed less than two-thirds of patients with severe CAP received antibiotics within the recommended 4 hours of admission.

The researchers streamlined management procedures in an effort to expand the number of patients treated within the target time. The team then compared results in the winter of 2001-2002, before the intervention, with those following the intervention in the winter of 2002-2003.

The proportion of patients appropriately treated rose from 33% to 56% at the intervention site, but only from 32% to 36% at a control site.

The basic cost per additional patient so treated was calculated to be 132 pounds sterling. This rose to 456 pounds when limited post-implementation evaluation was included. Corresponding costs per death prevented, were estimated to be 3003 and 16,332 pounds.

Summing up, Dr. Barlow noted that "this may well be a cost- effective strategy to decrease deaths, although there is still ongoing debate by experts about the importance of the door-to-needle time process in pneumonia."

Thorax 2007;62:67-74.
http://www.medscape.com/viewarticle/550802 Intervention Speeds Community-Acquired Pneumonia Therapy
有效干预加速社区获得性肺炎的治疗

By David Douglas

NEW YORK (Reuters Health) Jan 15 - Improved management has prompted a substantial increase in the number of patients with community-acquired pneumonia (CAP) who receive appropriate antibiotics in a timely fashion, UK researchers report in the January issue of Thorax.
纽约路透社健康栏目1月15日消息:英国研究人员发表在一月份《Thorax》杂志上的一篇报道认为:改良的治疗措施可显著增加患社区获得性肺炎community-acquired pneumonia (CAP)并及时接受适当抗生素治疗的患者数目。

As lead investigator Dr. Gavin Barlow told Reuters Health, "National Health Service hospitals can potentially reduce door-to-needle time for patients with pneumonia by implementing a relatively simple intervention."
第一作者Dr. Gavin Barlow向纽约路透社健康栏目解释说:“英国全国健康服务医院(National Health Service (NHS) hospitals)通过采用相对简单的干预措施,有望缩短肺炎患者就诊时间。”

Dr. Barlow of Castle Hill Hospital, Cottingham and colleagues note that an audit showed less than two-thirds of patients with severe CAP received antibiotics within the recommended 4 hours of admission.
Cottingham的Castle Hill医院的Dr. Barlow及其同事称,一项数据统计显示,少于三分之二患重度CAP的病人能够按推荐在入院4小时内接受抗生素治疗。

The researchers streamlined management procedures in an effort to expand the number of patients treated within the target time. The team then compared results in the winter of 2001-2002, before the intervention, with those following the intervention in the winter of 2002-2003.
研究人员改良了治疗流程,以增加推荐时间内能得到治疗的病人数。接着他们将进行干预前的2001-2002年的冬季的研究结果,与干预后的2002-2003年的冬季的研究结果进行了比较。

The proportion of patients appropriately treated rose from 33% to 56% at the intervention site, but only from 32% to 36% at a control site.
在进行干预的地区,接受适当治疗的病人的比例由33%上升到56%,而在作为对照的地区,这一数字仅由32%上升到36%。

The basic cost per additional patient so treated was calculated to be 132 pounds sterling. This rose to 456 pounds when limited post-implementation evaluation was included. Corresponding costs per death prevented, were estimated to be 3003 and 16,332 pounds.
每增加一名进行干预治疗的病人,所多花费的基本治疗费用为132英镑。而整个干预措施若还包括有限的干预后评估,则这一数字将上升到456英镑。但相应的,每减少一名病人的死亡,则上述两项费用分别可节约3003英镑和16332英镑。

Summing up, Dr. Barlow noted that "this may well be a cost- effective strategy to decrease deaths, although there is still ongoing debate by experts about the importance of the door-to-needle time process in pneumonia."
Dr. Barlow总结道“就降低死亡率来讲,这可能是种高性价比的治疗策略。然而,那些质疑就诊时间在肺炎治疗中的重要性的专家,仍对我们的结论存在疑虑。”

阅读本文的人还阅读:

德批准一种治疗前列腺癌

【科普】家禽的操作与消

【medical-news】局限期进展

【medical-news】很奇怪最近

放疗与基因疗法组合使用

作者:admin@医学,生命科学    2011-09-18 17:13
医学,生命科学网